Preview

Current Pediatrics

Advanced search

TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN RUSSIA (PROBLEMS AND SOLUTIONS IN XXI CENTURY)

Abstract

The article summarizes the results of diversified epidemiological and clinical study performed in Russian Federation. The peculiarities of tuberculosis infection in modern epidemiological situation, clinical symptoms of a disease and risk factors of its development are described. New risk groups of tuberculosis infection are children who need common observation within management of inflammatory rheumatic diseases and other chronic pathology treated with immunosuppressive agents. Authors show the necessity of differentiative approach to the prophylaxis and early diagnostics of tuberculosis within phthisiologic and common pediatric healthcare services.
Key words: children, tuberculosis, prevalence, risk factors.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2011; 10 (3): 7–11)

About the Authors

V.A. Aksenova
Scientific Institute of Phthisiology and Pulmonology, I.M. Sechenov First Moscow State Medical University


T.A. Sevost'yanova
Scientific Institute of Phthisiology and Pulmonology, I.M. Sechenov First Moscow State Medical University


N.I. Klevno
Scientific Institute of Phthisiology and Pulmonology, I.M. Sechenov First Moscow State Medical University


V.N. Lapshina
Scientific Institute of Phthisiology and Pulmonology, I.M. Sechenov First Moscow State Medical University


References

1. Туберкулез в Российской Федерации. Аналитический обзор статистических показателей по туберкулезу. М. 2009. 223 с.

2. Фирсова В.А. Туберкулез у детей и подростков: диагностика, клиника, лечение. Проблемы туберкулеза. 2003; 3: 23–26.

3. Борисов С.Е., Аксенова В.А., Леви Д.Т. и др. Диагностика туберкулезной инфекции при планировании и проведении терапии блокаторами ФНО–ᾳ у больных ревматическими заболеваниями. Пособие для врачей. М. 2008. 39 с.

4. Dfel P., Nienhaus A., Loddenkemper R. Cost effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germane. Chest. 2007; 131: 1424–1434.

5. Dixon W.G., Symmons D.P., Lunt M. et al. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum. 2007; 56 (9): 2896–2904.

6. Harboe M., Oettinger T., Wiker H.G et al. Evidence for occurrence of the ESAT 6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacteriuin bovis BCG. Infect. Immun. 1996; 64: 16–22.

7. Gómez–Reino J.J., Carmona L., Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 2007; 57 (5): 756–761.

8. Favalli E.G., Desiati F., Atzeni F. et al. Serious infections during anti–TNF alpha treatment in rheumatoid arthritis patients. Autoimmun. Rev. 2009; 8 (3): 266-273.

9. Askling J. Risk for tuberculosis following treatment of rheumatoid arthritis with anti–TNF therapy the Swedish experience 1998–2008. EULAR. 2009; FRI0200 (Abstract).

10. Arend S.A., Franken W.P., Aggerbeck H. et al. Double-blind randomized Phase I study comparing rd ESAT 6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis. 2008; 88: 249–261.

11. Brosch R., Gordon S.V., Billault А. et al. Use of Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect. Immun. 1998; 66: 2221–2229.


Review

For citations:


Aksenova V., Sevost'yanova T., Klevno N., Lapshina V. TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN RUSSIA (PROBLEMS AND SOLUTIONS IN XXI CENTURY). Current Pediatrics. 2011;10(3):7–11.

Views: 827


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)